跳至主要内容
临床试验/EUCTR2022-003737-19-BE
EUCTR2022-003737-19-BE进行中(未招募)1 期

Influence of sevoflurane and propofol on maximum muscular strength, speed of contraction and relaxation, in humans: A pilot study.

CHU Brugmann0 个研究点目标入组 48 人开始时间: 2022年11月29日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
CHU Brugmann
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • -Patients (male or female) from 18 – 80 years
  • -Scheduled for surgery without the use of neuromuscular blocking agents
  • -Health care insurance in Belgium
  • -Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 36
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 12

排除标准

  • -Any pathology involving neuromuscular transmission
  • -Confirmed neuropathy of any origin
  • -Expected anesthesia duration < 30 min
  • -Renal insufficiency defined as a glomerular filtration rate < 40 mL/min/m2
  • -Hepatic insufficiency defined as an increase > 1.5 * normal value of hepatic enzymes
  • -Confirmed or suspected pregnancy
  • -Language barrier
  • -Any patient which will receive unplanned neuromuscular blocking agents during surgery
  • -Any history of personal or familial suspected malignant hyperthermia

研究者

发起方
CHU Brugmann

相似试验